Ledger.

Professor, University of South Australia

Professor Stuart Pitson

Coverage

Stories naming Professor Stuart Pitson. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.

2 deals

Manufacturing news briefs – stories you might have missed

Roundup of Australian manufacturing items: Manildra draws on CEFC money to quit coal, Ankere Therapeutics launches with seed backing, Micro-X gear reaches Ukraine, plus a vessel naming, precinct tenders, an FFI appointment and a cable rebrand.

@AuManufacturing Fri 6 May 2022 Ankere TherapeuticsAustralian ArmyClean Energy Finance CorporationFortescueFortescue Future IndustriesGeneral Motors HoldenGood Design AwardMcKinsey & CompanyMicro-X LtdMonash Institute of Pharmaceutical SciencesNexansRegional Development VictoriaUniversity of MelbourneUniversity of South AustraliaYamba Welding and EngineeringProfessor Bernard FlynnChristiaan HeyningGreg StackIan LearmonthRick BurrProfessor Stuart Pitson
Seed $10m

Australian collaboration and AU$10m investment fuels Ankere Therapeutics’ efforts to target inflammatory lung conditions

Biotech startup Ankere Therapeutics launches with a $10 million seed round co-led by IP Group and Brandon Capital to develop inflammatory lung disease therapies, building on research from Monash and UniSA scientists.

Brandon BioCatalyst portfolio Tue 3 May 2022 Ankere TherapeuticsAkeyulerreBrandon BioCatalystCannings Strategic CommunicationsCentre for Cancer BiologyGo8 UniversitiesMana CommunicationsMonash Institute of Pharmaceutical SciencesMonash UniversitySA PathologyUniversity of South AustraliaBrandon CapitalIP Group AustraliaAileen BodartAssociate Professor Bernard FlynnProfessor Bernard FlynnCiara ByrneDr Melissa McBurnieDr Siro PerezProfessor Stuart Pitson

Also Brandon Capital portfolio·Startup Daily·@AuManufacturing

2 deals

Biomedical Translation Bridge Program grants $1m to develop a drug treatment for obesity-related health conditions

Cincera Therapeutics has received a million-dollar Biomedical Translation Bridge grant to advance its Des-1 inhibitor drug for obesity-related metabolic diseases. The Monash and UniSA spin-out previously secured venture funding from the Medical Research Commercialisation Fund.

Brandon BioCatalyst portfolio Thu 3 Sep 2020 Cincera TherapeuticsBioCurateBrandon Capital PartnersBridge and BridgeTech programsCALHNCentre for Cancer BiologyFlinders UniversityMedical Device Partnering ProgramMedical Research Future FundMonash Institute of Pharmaceutical SciencesMonash UniversityMTPConnectQueensland University of TechnologyUniQuestUniSA Ventures Pty LtdUniversity of MelbourneUniversity of QueenslandUniversity of South AustraliaBiomedical Translation BridgeMedical Research Commercialisation Fund (MRCF)Associate Professor Bernard FlynnDr Michael BettessProfessor Stuart Pitson

Also Brandon Capital portfolio·cinceratx.com

Something wrong? Tell us